Research Projects
Clinical registries play an important role in measuring healthcare delivery, supporting quality improvement and evaluating clinical outcomes,...
Supervisor: A/Prof Jun Yang
Despite growing evidence for the high prevalence of primary aldosteronism in people with hypertension, it remains under-diagnosed. However, it is not...
Supervisor: A/Prof Jun Yang
Primary aldosteronism (PA) is the most common, and a potentially curable, cause of hypertension, estimated to affect 5-10% of all hypertensive...
Supervisor: A/Prof Jun Yang
Whilst dichotomous thresholds are currently used to diagnose primary aldosteronism (PA), emerging data support the concept of a continuum of...
Supervisor: A/Prof Jun Yang
Ethnic differences exist in the pathogenesis, prevalence and complications of hypertension. There is a body of work on the high prevalence of low-...
Supervisor: A/Prof Jun Yang
Primary aldosteronism affects ~ 10% of hypertensive patients. It is unclear what proportion of women who are diagnosed with hypertension during or...
Supervisor: A/Prof Jun Yang
Resistant hypertension is estimated to affect ~25% of hypertensive patients on treatment. Screening for a secondary cause such as primary...
Supervisor: A/Prof Jun Yang